Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
2000-08-08
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514265, 544268, 544269, 544271, A61K 31522, C07D47310
Patent
active
061002712
ABSTRACT:
Therapeutic compounds with at least one carboxylic acid, ester or amide-substituted side chain have the formula:
REFERENCES:
patent: 3422107 (1969-01-01), Mohler et al.
patent: 3734911 (1973-05-01), Bestian
patent: 3737433 (1973-06-01), Mohler et al.
patent: 3896127 (1975-07-01), Takahashi et al.
patent: 3984413 (1976-10-01), Metz et al.
patent: 4153803 (1979-05-01), Thiele et al.
patent: 4273866 (1981-06-01), Voss
patent: 4275064 (1981-06-01), Bodor et al.
patent: 4302438 (1981-11-01), Zech
patent: 4460772 (1984-07-01), Benovic et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4713165 (1987-12-01), Conover
patent: 4737502 (1988-04-01), Busacca
patent: 4833146 (1989-05-01), Gebert et al.
patent: 4965271 (1990-10-01), Mandell et al.
patent: 5039666 (1991-08-01), Novick, Jr.
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5112827 (1992-05-01), Saunders et al.
patent: 5118500 (1992-06-01), Hanel
patent: 5288721 (1994-02-01), Klein et al.
patent: 5670506 (1997-09-01), Leigh
patent: B13737433 (1987-03-01), Mohler et al.
Bianco et al., Blood, 76: Supplement 1 (522), p. 133a, "Pentoxifylline (PTX) and GM-CSF Decrease Tumor Necrosis Factor-ALPHA (TNF-.alpha.) Levels in Patients Undergoing Allogenic Bone Marrow Transplantation (BMT)", 1990.
Bryce et al., Arzneim.-Forsch./Drug Res., 39:4, pp. 512-517. "Metabolism and Pharmacokinetics of .sup.14 C-Pentoxifylline in Healthy Volunteers", 1989.
Davis et al., Applied Environment Microbiol., 48:2, pp. 327-331, "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxifylline", 1984.
Klein J. Peter
Kumar Anil M.
Leigh Alistair J.
Underiner Gail E.
Berch Mark L.
Cell Therapeutics Inc.
LandOfFree
Therapeutic compounds containing xanthinyl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compounds containing xanthinyl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds containing xanthinyl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1150466